Why Novartis (NVS) Stock Fell Today

By: Quiver PriceTracker

Posted: 5 hours ago / July 6, 2026 4:19 p.m. UTC

NVS

Novartis AG (NVS) is down 3.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The clearest catalyst appears to be Novartis’s agreement to acquire Myricx Bio in a deal valued at up to $1.5 billion. Investors often mark down large pharmaceutical buyers on acquisition days when a transaction involves meaningful upfront cash and early-stage pipeline risk, even if the strategic fit looks strong over the long term.

Details:

Novartis announced on July 6 that it will buy Myricx Bio for $1.1 billion upfront, with up to $400 million in additional milestone payments.

The target is developing a new class of antibody-drug conjugates using an N-myristoyltransferase inhibitor payload platform, which Novartis believes could help address resistance seen with current payload approaches.

The transaction also adds two lead oncology assets aimed at the B7-H3 and HER2 targets, expanding Novartis’s cancer pipeline across multiple solid tumor settings.

This could be because the market is balancing the long-term oncology opportunity against the near-term cost of the acquisition and the uncertainty that comes with preclinical and early-development assets.

Sources:

Novartis, GlobeNewswire, MarketScreener

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive NVS Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$NVS Hedge Fund Activity

We have seen 647 institutional investors add shares of $NVS stock to their portfolio, and 567 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FISHER ASSET MANAGEMENT, LLC added 6,419,899 shares (+86.0%) to their portfolio in Q1 2026, for an estimated $980,639,572
AUTO-OWNERS INSURANCE CO removed 4,594,726 shares (-99.3%) from their portfolio in Q1 2026, for an estimated $701,844,396
GOLDMAN SACHS GROUP INC added 3,781,588 shares (+137.8%) to their portfolio in Q1 2026, for an estimated $577,637,567
DODGE & COX removed 2,047,258 shares (-22.7%) from their portfolio in Q1 2026, for an estimated $312,718,659
JONES FINANCIAL COMPANIES LLLP added 1,625,514 shares (+828.2%) to their portfolio in Q1 2026, for an estimated $248,297,263
WCM INVESTMENT MANAGEMENT, LLC added 1,463,180 shares (+inf%) to their portfolio in Q1 2026, for an estimated $223,500,745
NATIXIS ADVISORS, LLC added 1,397,774 shares (+166.7%) to their portfolio in Q1 2026, for an estimated $213,509,978

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.